These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28481930)

  • 21. Antiapoptotic Bcl-2 homolog CED-9 in Caenorhabditis elegans: dynamics of BH3 and CED-4 binding regions and comparison with mammalian antiapoptotic Bcl-2 proteins.
    Modi V; Sankararamakrishnan R
    Proteins; 2014 Jun; 82(6):1035-47. PubMed ID: 24218065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and pharmacological profiling of the pro-survival protein Bcl-xL.
    Goreshnik I; Brock AM; Maly DJ
    Bioorg Med Chem Lett; 2011 Sep; 21(17):4951-5. PubMed ID: 21807512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein phosphatase 6 controls BCR-induced apoptosis of WEHI-231 cells by regulating ubiquitination of Bcl-xL.
    Kajihara R; Sakamoto H; Tanabe K; Takemoto K; Tasaki M; Ando Y; Inui S
    J Immunol; 2014 Jun; 192(12):5720-9. PubMed ID: 24808369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
    Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
    Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The long unstructured region of Bcl-xl modulates its structural dynamics.
    Priya P; Maity A; Ghosh Dastidar S
    Proteins; 2017 Aug; 85(8):1567-1579. PubMed ID: 28486788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ryanodine receptors are targeted by anti-apoptotic Bcl-XL involving its BH4 domain and Lys87 from its BH3 domain.
    Vervliet T; Lemmens I; Vandermarliere E; Decrock E; Ivanova H; Monaco G; Sorrentino V; Nadif Kasri N; Missiaen L; Martens L; De Smedt H; Leybaert L; Parys JB; Tavernier J; Bultynck G
    Sci Rep; 2015 Apr; 5():9641. PubMed ID: 25872771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The N-terminal domain of tumor suppressor p53 is involved in the molecular interaction with the anti-apoptotic protein Bcl-Xl.
    Xu H; Tai J; Ye H; Kang CB; Yoon HS
    Biochem Biophys Res Commun; 2006 Mar; 341(4):938-44. PubMed ID: 16455050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
    Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line.
    Fiebig AA; Zhu W; Hollerbach C; Leber B; Andrews DW
    BMC Cancer; 2006 Aug; 6():213. PubMed ID: 16928273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4.
    Huang DC; Adams JM; Cory S
    EMBO J; 1998 Feb; 17(4):1029-39. PubMed ID: 9463381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
    Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Bcl-2 cannot directly inhibit the Caenorhabditis elegans Apaf-1 homologue CED-4, but can interact with EGL-1.
    Jabbour AM; Puryer MA; Yu JY; Lithgow T; Riffkin CD; Ashley DM; Vaux DL; Ekert PG; Hawkins CJ
    J Cell Sci; 2006 Jun; 119(Pt 12):2572-82. PubMed ID: 16735440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental abnormality induced by strong static magnetic field in Caenorhabditis elegans.
    Wang L; Du H; Guo X; Wang X; Wang M; Wang Y; Wang M; Chen S; Wu L; Xu A
    Bioelectromagnetics; 2015 Apr; 36(3):178-89. PubMed ID: 25754967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pro-apoptotic effects of splice-switching oligonucleotides targeting Bcl-x pre-mRNA in human glioma cell lines.
    Li Z; Li Q; Han L; Tian N; Liang Q; Li Y; Zhao X; Du C; Tian Y
    Oncol Rep; 2016 Feb; 35(2):1013-9. PubMed ID: 26718027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer.
    Masui T; Hosotani R; Ito D; Kami K; Koizumi M; Mori T; Toyoda E; Nakajima S; Miyamoto Y; Fujimoto K; Doi R
    Surgery; 2006 Aug; 140(2):149-60. PubMed ID: 16904964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the membrane-inserted C-terminus of cytoprotective BCL-XL.
    Yao Y; Nisan D; Fujimoto LM; Antignani A; Barnes A; Tjandra N; Youle RJ; Marassi FM
    Protein Expr Purif; 2016 Jun; 122():56-63. PubMed ID: 26923059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EGL-1 BH3 mutants reveal the importance of protein levels and target affinity for cell-killing potency.
    Lee EF; Chen L; Yang H; Colman PM; Huang DC; Fairlie WD
    Cell Death Differ; 2008 Oct; 15(10):1609-18. PubMed ID: 18566606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoglobulin kappa and immunoglobulin lambda are required for expression of the anti-apoptotic molecule Bcl-xL in human colorectal cancer tissue.
    Yang SB; Chen X; Wu BY; Wang MW; Cai CH; Cho DB; Chong J; Li P; Tang SG; Yang PC
    Scand J Gastroenterol; 2009; 44(12):1443-51. PubMed ID: 19883274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA Bcl-xL-expressing oncolytic adenovirus through enhanced viral replication and cellular arrest.
    Kang S; Kang D; Bakhtiar Ul Islam SM; Je S; Kim JH; Song JJ
    Cell Signal; 2015 Jun; 27(6):1214-24. PubMed ID: 25748050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Bcl-xL by ABT-737 enhances chemotherapy sensitivity in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumor cells.
    Lee SJ; Park HJ; Kim YH; Kim BY; Jin HS; Kim HJ; Han JH; Yim H; Jeong SY
    Int J Mol Med; 2012 Aug; 30(2):443-50. PubMed ID: 22664653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.